111 related articles for article (PubMed ID: 11172300)
1. Cyclin E immunoexpression in breast ductal carcinoma: pathologic correlations and prognostic implications.
Donnellan R; Kleinschmidt I; Chetty R
Hum Pathol; 2001 Jan; 32(1):89-94. PubMed ID: 11172300
[TBL] [Abstract][Full Text] [Related]
2. Cyclin E expression in operable breast cancer quantified using real-time RT-PCR: a comparative study with immunostaining.
Potemski P; Pluciennik E; Bednarek AK; Kusinska R; Jesionek-Kupnicka D; Pasz-Walczak G; Watala C; Kordek R
Jpn J Clin Oncol; 2006 Mar; 36(3):142-9. PubMed ID: 16520356
[TBL] [Abstract][Full Text] [Related]
3. The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.
Voduc D; Nielsen TO; Cheang MC; Foulkes WD
Hum Pathol; 2008 Oct; 39(10):1431-7. PubMed ID: 18620730
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast.
Lee A; Park WC; Yim HW; Lee MA; Park G; Lee KY
Jpn J Clin Oncol; 2007 Sep; 37(9):708-14. PubMed ID: 17940078
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometry and quantitative immunohistochemical study of cell cycle regulation proteins in invasive breast carcinoma: prognostic significance.
Michels JJ; Duigou F; Marnay J; Henry-Amar M; Delozier T; Denoux Y; Chasle J
Cancer; 2003 Mar; 97(6):1376-86. PubMed ID: 12627500
[TBL] [Abstract][Full Text] [Related]
6. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
Hussein MR; Abd-Elwahed SR; Abdulwahed AR
Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
[TBL] [Abstract][Full Text] [Related]
7. Aberrant expression of cyclin E in low-risk node negative breast cancer.
Ahlin C; Gruhne B; Holmqvist M; Zetterberg A; Fjällskog ML
Acta Oncol; 2008; 47(8):1539-45. PubMed ID: 18607847
[TBL] [Abstract][Full Text] [Related]
8. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of cyclin E expression in operable breast cancer.
Potemski P; Kusińska R; Pasz-Walczak G; Piekarski JH; Watała C; Płuciennik E; Bednarek AK; Kordek R
Med Sci Monit; 2009 Feb; 15(2):MT34-40. PubMed ID: 19179977
[TBL] [Abstract][Full Text] [Related]
10. Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma.
Lim SC
Oncol Rep; 2003; 10(5):1241-9. PubMed ID: 12883688
[TBL] [Abstract][Full Text] [Related]
11. Stromal expression of CD10 in invasive breast carcinoma: a new predictor of clinical outcome.
Iwaya K; Ogawa H; Izumi M; Kuroda M; Mukai K
Virchows Arch; 2002 Jun; 440(6):589-93. PubMed ID: 12070597
[TBL] [Abstract][Full Text] [Related]
12. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
13. Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer.
Arnes JB; Brunet JS; Stefansson I; Bégin LR; Wong N; Chappuis PO; Akslen LA; Foulkes WD
Clin Cancer Res; 2005 Jun; 11(11):4003-11. PubMed ID: 15930334
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer.
Huang J; Tan PH; Thiyagarajan J; Bay BH
Mod Pathol; 2003 Jun; 16(6):558-65. PubMed ID: 12808061
[TBL] [Abstract][Full Text] [Related]
15. Angiogenesis and some prognostic parameters of invasive ductal breast carcinoma in women.
Olewniczak S; Chosia M; Kwas A; Kram A; Domagała W
Pol J Pathol; 2002; 53(4):183-8. PubMed ID: 12597334
[TBL] [Abstract][Full Text] [Related]
16. Cyclin E expression in breast cancer correlates with negative steroid receptor status, HER2 expression, tumor grade and proliferation.
Potemski P; Kusinska R; Watala C; Pluciennik E; Bednarek AK; Kordek R
J Exp Clin Cancer Res; 2006 Mar; 25(1):59-64. PubMed ID: 16761619
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value.
van Diest PJ; Michalides RJ; Jannink L; van der Valk P; Peterse HL; de Jong JS; Meijer CJ; Baak JP
Am J Pathol; 1997 Feb; 150(2):705-11. PubMed ID: 9033283
[TBL] [Abstract][Full Text] [Related]
18. Cyclin E confers a prognostic value in premenopausal breast cancer patients with tumours exhibiting an infiltrative growth pattern.
Berglund P; Stighall M; Jirström K; Rydén L; Fernö M; Nordenskjöld B; Landberg G
J Clin Pathol; 2008 Feb; 61(2):184-91. PubMed ID: 17483245
[TBL] [Abstract][Full Text] [Related]
19. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
Masiuk M
Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
[TBL] [Abstract][Full Text] [Related]
20. Accurate assessment of lymph vessel tumor emboli in invasive ductal carcinoma of the breast according to tumor areas, and their prognostic significance.
Yamauchi C; Hasebe T; Iwasaki M; Imoto S; Wada N; Fukayama M; Ochiai A
Hum Pathol; 2007 Feb; 38(2):247-59. PubMed ID: 17056095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]